ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.

Anne F Luetkemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.